Setting

North America Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity

Published: 30 Jun 2021 | Report Code: 10248053 | Pages: 95

North America biosurgery market is expected to grow by 5.9% annually in the forecast period and reach $8,079.9 million by 2027 owing to the growth in joint reconstruction and spinal fusion, the increasing number of surgeries especially minimally invasive surgeries due to lifestyle disorders and the rise in the overweight & aging population. Highlighted with 24 tables and 46 figures, this 95-page report “North America Biosurgery Market 2020-2027 by Product, Source Type (Natural, Synthetic), Application (Orthopedic, General, Neurological, Cardiovascular), and Country: Trend Outlook and Growth Opportunity” is based on a comprehensive research of the entire North America biosurgery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America biosurgery market in every aspect of the classification from perspectives of Product, Source Type, Application, and Country. Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Hemostatic Agents • Bone-graft Substitutes o Synthetic Graft Extender o Demineralized Bone Matrix o Bone Morphogenetic Proteins o Cell-Based Matrices • Surgical Sealants and Adhesives o Natural Surgical Sealing Agents o Synthetic Surgical Sealing Agents • Soft-tissue Attachments o Natural & Biological Mesh/Patch o Synthetic Mesh/Patch • Adhesion Barriers o Natural Adhesion Barriers o Synthetic Adhesion Barriers • Staple Line Reinforcement Based on Source Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Natural/Biological Products • Synthetic Products Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2017-2027 included in each section. • Orthopedic Surgery • General Surgery • Neurological Surgery • Cardiovascular Surgery • Gynecological Surgery • Other Applications Geographically, the following national/local markets are fully investigated: • U.S. • Canada • Mexico For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2017-2027. The breakdown of key national markets by Product, Source Type, and Application over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Key Players (this may not be a complete list and extra companies can be added upon request): B. Braun Melsungen AG Baxter International, Inc. Becton, Dickinson and Company (C.R. Bard) Betatech Medical CryoLife Inc. CSL Limited Hemostasis LLC Integra Lifesciences Holdings Corporation Johnson & Johnson Medtronic PLC Pfizer, Inc. Sanofi S.A. Stryker Corporation (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	5
1.1 Industry Definition and Research Scope	5
1.1.1 Industry Definition	5
1.1.2 Research Scope	6
1.2 Research Methodology	9
1.2.1 Overview of Market Research Methodology	9
1.2.2 Market Assumption	10
1.2.3 Secondary Data	10
1.2.4 Primary Data	10
1.2.5 Data Filtration and Model Design	11
1.2.6 Market Size/Share Estimation	12
1.2.7 Research Limitations	13
1.3 Executive Summary	14
2 Market Overview and Dynamics	16
2.1 Market Size and Forecast	16
2.1.1 Impact of COVID-19 on World Economy	17
2.1.2 Impact of COVID-19 on the Market	19
2.2 Major Growth Drivers	21
2.3 Market Restraints and Challenges	25
2.4 Emerging Opportunities and Market Trends	28
2.5 Porter’s Fiver Forces Analysis	32
3 Segmentation of North America Market by Product	36
3.1 Market Overview by Product	36
3.2 Hemostatic Agents	38
3.3 Bone-graft Substitutes	39
3.2.1 Synthetic Graft Extender	40
3.2.2 Demineralized Bone Matrix	41
3.2.3 Bone Morphogenetic Proteins	42
3.2.4 Cell-Based Matrices	43
3.4 Surgical Sealants and Adhesives	44
3.4.1 Natural Surgical Sealing Agents	45
3.4.2 Synthetic Surgical Sealing Agents	46
3.5 Soft-tissue Attachments	47
3.5.1 Natural & Biological Mesh/Patch	48
3.5.2 Synthetic Mesh/Patch	49
3.6 Adhesion Barriers	50
3.6.1 Natural Adhesion Barriers	51
3.6.2 Synthetic Adhesion Barriers	52
3.7 Staple Line Reinforcement	53
4 Segmentation of North America Market by Source Type	54
4.1 Market Overview by Source Type	54
4.2 Natural/Biological Products	56
4.3 Synthetic Products	57
5 Segmentation of North America Market by Application	59
5.1 Market Overview by Application	59
5.2 Orthopedic Surgery	61
5.3 General Surgery	62
5.4 Neurological Surgery	63
5.5 Cardiovascular Surgery	64
5.6 Gynecological Surgery	65
5.7 Other Applications	66
6 North America Market 2020-2027 by Country	67
6.1 Overview of North America Market	67
6.2 U.S.	70
6.3 Canada	73
6.4 Mexico	75
7 Competitive Landscape	77
7.1 Overview of Key Vendors	77
7.2 New Product Launch, Partnership, Investment, and M&A	80
7.3 Company Profiles	81
B. Braun Melsungen AG	81
Baxter International, Inc.	83
Becton, Dickinson and Company (C.R. Bard)	84
Betatech Medical	85
CryoLife Inc.	86
CSL Limited	87
Hemostasis LLC	88
Integra Lifesciences Holdings Corporation	89
Johnson & Johnson	90
Medtronic PLC	91
Pfizer, Inc.	92
Sanofi S.A.	93
Stryker Corporation	94
RELATED REPORTS	95

List Of Tables

Table 1.  Snapshot of North America Biosurgery Market in Balanced Perspective, 2020-2027	15
Table 2. Growth Rate of World GDP, 2020-2022	18
Table 3.  Main Product Trends and Market Opportunities in North America Biosurgery Market	28
Table 4. North America Biosurgery Market by Product, 2017-2027, $ mn	36
Table 5. North America Biosurgery Market: Bone-Graft Substitutes by Type, 2017-2027, $ mn	39
Table 6. North America Biosurgery Market: Surgical Sealants and Adhesives by Type, 2017-2027, $ mn	44
Table 7. North America Biosurgery Market: Soft-tissue Attachments by Type, 2017-2027, $ mn	47
Table 8. North America Biosurgery Market: Adhesion Barriers by Type, 2017-2027, $ mn	50
Table 9. North America Biosurgery Market by Source Type, 2017-2027, $ mn	54
Table 10. North America Biosurgery Market by Application, 2017-2027, $ mn	59
Table 11. North America Biosurgery Market by Country, 2017-2027, $ mn	68
Table 12. U.S. Biosurgery Market by Product, 2017-2027, $ mn	72
Table 13. U.S. Biosurgery Market by Source Type, 2017-2027, $ mn	72
Table 14. U.S. Biosurgery Market by Application, 2017-2027, $ mn	72
Table 15. Canada Biosurgery Market by Product, 2017-2027, $ mn	74
Table 16. Canada Biosurgery Market by Source Type, 2017-2027, $ mn	74
Table 17. Canada Biosurgery Market by Application, 2017-2027, $ mn	74
Table 18. Mexico Biosurgery Market by Product, 2017-2027, $ mn	76
Table 19. Mexico Biosurgery Market by Source Type, 2017-2027, $ mn	76
Table 20. Mexico Biosurgery Market by Application, 2017-2027, $ mn	76
Table 21. B. Braun Melsungen AG: Company Snapshot	81
Table 22. B. Braun Melsungen AG: Business Segmentation	81
Table 23. B. Braun Melsungen AG: Product Portfolio	82
Table 24. B. Braun Melsungen AG: Revenue, 2017-2019, $ mn	82
List Of Figures

Figure 1. Research Method Flow Chart	9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	12
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027	14
Figure 4. North America Biosurgery Market, 2017-2027, $ mn	16
Figure 5. Impact of COVID-19 on Business	19
Figure 6. Primary Drivers and Impact Factors of North America Biosurgery Market	21
Figure 7.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	24
Figure 8. Primary Restraints and Impact Factors of North America Biosurgery Market	25
Figure 9. Investment Opportunity Analysis	29
Figure 10. Porter’s Fiver Forces Analysis of North America Biosurgery Market	32
Figure 11. Breakdown of North America Biosurgery Market by Product, 2020-2027, % of Revenue	36
Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Product, Value ($ mn) and Share (%)	37
Figure 13. North America Biosurgery Market: Hemostatic Agents, 2017-2027, $ mn	38
Figure 14. North America Biosurgery Market: Bone-graft Substitutes, 2017-2027, $ mn	39
Figure 15. North America Biosurgery Market: Synthetic Graft Extender, 2017-2027, $ mn	40
Figure 16. North America Biosurgery Market: Demineralized Bone Matrix, 2017-2027, $ mn	41
Figure 17. North America Biosurgery Market: Bone Morphogenetic Proteins, 2017-2027, $ mn	42
Figure 18. North America Biosurgery Market: Cell-Based Matrices, 2017-2027, $ mn	43
Figure 19. North America Biosurgery Market: Surgical Sealants and Adhesives, 2017-2027, $ mn	44
Figure 20. North America Biosurgery Market: Natural Surgical Sealing Agents, 2017-2027, $ mn	45
Figure 21. North America Biosurgery Market: Synthetic Surgical Sealing Agents, 2017-2027, $ mn	46
Figure 22. North America Biosurgery Market: Soft-tissue Attachments, 2017-2027, $ mn	47
Figure 23. North America Biosurgery Market: Natural & Biological Mesh/Patch, 2017-2027, $ mn	48
Figure 24. North America Biosurgery Market: Synthetic Mesh/Patch, 2017-2027, $ mn	49
Figure 25. North America Biosurgery Market: Adhesion Barriers, 2017-2027, $ mn	50
Figure 26. North America Biosurgery Market: Natural Adhesion Barriers, 2017-2027, $ mn	51
Figure 27. North America Biosurgery Market: Synthetic Adhesion Barriers, 2017-2027, $ mn	52
Figure 28. North America Biosurgery Market: Staple Line Reinforcement, 2017-2027, $ mn	53
Figure 29. Breakdown of North America Biosurgery Market by Source Type, 2020-2027, % of Revenue	54
Figure 30. Contribution to North America 2021-2027 Cumulative Revenue by Source Type, Value ($ mn) and Share (%)	55
Figure 31. North America Biosurgery Market: Natural/Biological Products, 2017-2027, $ mn	56
Figure 32. North America Biosurgery Market: Synthetic Products, 2017-2027, $ mn	57
Figure 33. Breakdown of North America Biosurgery Market by Application, 2020-2027, % of Revenue	60
Figure 34. Contribution to North America 2021-2027 Cumulative Revenue by Application, Value ($ mn) and Share (%)	60
Figure 35. North America Biosurgery Market: Orthopedic Surgery, 2017-2027, $ mn	61
Figure 36. North America Biosurgery Market: General Surgery, 2017-2027, $ mn	62
Figure 37. North America Biosurgery Market: Neurological Surgery, 2017-2027, $ mn	63
Figure 38. North America Biosurgery Market: Cardiovascular Surgery, 2017-2027, $ mn	64
Figure 39. North America Biosurgery Market: Gynecological Surgery, 2017-2027, $ mn	65
Figure 40. North America Biosurgery Market: Other Applications, 2017-2027, $ mn	66
Figure 41. Breakdown of North America Biosurgery Market by Country, 2020 and 2027, % of Revenue	68
Figure 42. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value ($ mn) and Share (%)	69
Figure 43. U.S. Biosurgery Market, 2017-2027, $ mn	71
Figure 44. Canada Biosurgery Market, 2017-2027, $ mn	73
Figure 45.  Biosurgery Market in Mexico, 2017-2027, $ mn	75
Figure 46. Growth Stage of North America Biosurgery Industry over the Forecast Period	77

Key Players (this may not be a complete list and extra companies can be added upon request): 
B. Braun Melsungen AG
Baxter International, Inc.
Becton, Dickinson and Company (C.R. Bard)
Betatech Medical
CryoLife Inc.
CSL Limited
Hemostasis LLC
Integra Lifesciences Holdings Corporation
Johnson & Johnson
Medtronic PLC
Pfizer, Inc.
Sanofi S.A.
Stryker Corporation
 (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)